{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T21:29:28Z","timestamp":1777498168688,"version":"3.51.4"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T00:00:00Z","timestamp":1752537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T00:00:00Z","timestamp":1752537600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Research Fund of the Health and Family Planning Commission of Nantong, Jiangsu Province","award":["WKZL2018019"],"award-info":[{"award-number":["WKZL2018019"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Histol"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s10735-025-10468-6","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T14:48:57Z","timestamp":1752590937000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["SOX4 promotes triple-negative breast cancer progression by promoting SRPX2\u00a0transcription to regulate AKR1C1"],"prefix":"10.1007","volume":"56","author":[{"given":"Weiwei","family":"Ge","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun","family":"Ge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siyun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuhua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinfeng","family":"Qian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,15]]},"reference":[{"issue":"7","key":"10468_CR1","doi-asserted-by":"publisher","first-page":"3434","DOI":"10.1158\/0008-5472.CAN-05-3456","volume":"66","author":"M Aaboe","year":"2006","unstructured":"Aaboe M, Birkenkamp-Demtroder K, Wiuf C, S\u00f8rensen FB, Thykjaer T, Sauter G et al (2006) SOX4 expression in bladder carcinoma: clinical aspects and in vitro functional characterization. Cancer Res 66(7):3434\u20133442","journal-title":"Cancer Res"},{"issue":"9","key":"10468_CR2","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.2174\/0115701808253017231016041343","volume":"21","author":"H Abdullah","year":"2024","unstructured":"Abdullah H, Neelaveni T, Mohammed A, Asim N, Hassan Ahmed Al H, Durgaramani S et al (2024) In-silico binding, stability, pharmacokinetics, and toxicity studies on natural ambrox metabolites as binding ligands to luminal B and Triple-negative\/basal-like proteins for breast Cancer therapy. Lett Drug Des Discov 21(9):1569\u20131581","journal-title":"Lett Drug Des Discov"},{"issue":"1","key":"10468_CR3","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.ccell.2020.12.001","volume":"39","author":"A Bagati","year":"2021","unstructured":"Bagati A, Kumar S, Jiang P, Pyrdol J, Zou AE, Godicelj A et al (2021) Integrin \u03b1v\u03b26-TGF\u03b2-SOX4 pathway drives immune evasion in Triple-Negative breast Cancer. Cancer Cell 39(1):54\u201367e59","journal-title":"Cancer Cell"},{"issue":"5","key":"10468_CR4","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1158\/0008-5472.CAN-15-1868","volume":"76","author":"B Bilir","year":"2016","unstructured":"Bilir B, Osunkoya AO, Wiles WGt, Sannigrahi S, Lefebvre V, Metzger D et al (2016) SOX4 is essential for prostate tumorigenesis initiated by PTEN ablation. Cancer Res 76(5):1112\u20131121","journal-title":"Cancer Res"},{"key":"10468_CR5","doi-asserted-by":"publisher","first-page":"101421","DOI":"10.1016\/j.tranon.2022.101421","volume":"20","author":"LL Chang","year":"2022","unstructured":"Chang LL, Lu PH, Yang W, Hu Y, Zheng L, Zhao Q et al (2022) AKR1C1 promotes non-small cell lung cancer proliferation via crosstalk between HIF-1\u03b1 and metabolic reprogramming. Transl Oncol 20:101421","journal-title":"Transl Oncol"},{"issue":"1","key":"10468_CR6","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s12943-020-01220-7","volume":"19","author":"X Chen","year":"2020","unstructured":"Chen X, Xu M, Xu X, Zeng K, Liu X, Pan B et al (2020) METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhibits tumor metastasis in colorectal cancer. Mol Cancer 19(1):106","journal-title":"Mol Cancer"},{"key":"10468_CR7","doi-asserted-by":"publisher","first-page":"108010","DOI":"10.1016\/j.pharmthera.2021.108010","volume":"232","author":"S Christgen","year":"2022","unstructured":"Christgen S, Tweedell RE, Kanneganti TD (2022) Programming inflammatory cell death for therapy. Pharmacol Ther 232:108010","journal-title":"Pharmacol Ther"},{"issue":"12","key":"10468_CR8","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1038\/s41419-019-2143-7","volume":"10","author":"M Gagliardi","year":"2019","unstructured":"Gagliardi M, Cotella D, Santoro C, Cor\u00e0 D, Barlev NA, Piacentini M et al (2019) Aldo-keto reductases protect metastatic melanoma from ER stress-independent ferroptosis. Cell Death Dis 10(12):902","journal-title":"Cell Death Dis"},{"issue":"5","key":"10468_CR9","first-page":"4791","volume":"8","author":"Z Gao","year":"2015","unstructured":"Gao Z, Zhang J, Bi M, Han X, Han Z, Wang H et al (2015) SRPX2 promotes cell migration and invasion via FAK dependent pathway in pancreatic cancer. Int J Clin Exp Pathol 8(5):4791\u20134798","journal-title":"Int J Clin Exp Pathol"},{"issue":"3","key":"10468_CR10","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.21037\/jgo-23-277","volume":"14","author":"C Gao","year":"2023","unstructured":"Gao C, Chang L, Xu T, Li X, Chen Z (2023) AKR1C1 overexpression leads to lenvatinib resistance in hepatocellular carcinoma. J Gastrointest Oncol 14(3):1412\u20131433","journal-title":"J Gastrointest Oncol"},{"issue":"8","key":"10468_CR11","doi-asserted-by":"publisher","first-page":"4825","DOI":"10.1007\/s10238-023-01113-1","volume":"23","author":"H Guo","year":"2023","unstructured":"Guo H, Liu R, Wu J, Li S, Yao W, Xu J et al (2023) SRPX2 promotes cancer cell proliferation and migration of papillary thyroid cancer. Clin Exp Med 23(8):4825\u20134834","journal-title":"Clin Exp Med"},{"issue":"Pt 1","key":"10468_CR13","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.semcancer.2019.06.022","volume":"67","author":"H Hanieh","year":"2020","unstructured":"Hanieh H, Ahmed EA, Vishnubalaji R, Alajez NM (2020) SOX4: epigenetic regulation and role in tumorigenesis. Semin Cancer Biol 67(Pt 1):91\u2013104","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"10468_CR14","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1186\/s12935-021-02267-2","volume":"21","author":"F Huang","year":"2021","unstructured":"Huang F, Zheng Y, Li X, Luo H, Luo L (2021) Ferroptosis-related gene AKR1C1 predicts the prognosis of non-small cell lung cancer. Cancer Cell Int 21(1):567","journal-title":"Cancer Cell Int"},{"key":"10468_CR15","doi-asserted-by":"crossref","unstructured":"Huang G, Cai Y, Ren M, Zhang X, Fu Y, Cheng R et al (2024) Salidroside sensitizes Triple-negative breast cancer to ferroptosis by SCD1-mediated lipogenesis and NCOA4-mediated ferritinophagy. J Adv Res S2090-1232(24):00429-6","DOI":"10.1016\/j.jare.2024.09.027"},{"issue":"4","key":"10468_CR16","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1200\/JGO.2016.008318","volume":"3","author":"H Iwata","year":"2017","unstructured":"Iwata H, Im SA, Masuda N, Im YH, Inoue K, Rai Y et al (2017) PALOMA-3: phase III trial of fulvestrant with or without Palbociclib in premenopausal and postmenopausal women with hormone receptor-Positive, human epidermal growth factor receptor 2-Negative metastatic breast Cancer that progressed on prior endocrine Therapy-Safety and efficacy in Asian patients. J Glob Oncol 3(4):289\u2013303","journal-title":"J Glob Oncol"},{"issue":"4","key":"10468_CR17","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","volume":"22","author":"X Jiang","year":"2021","unstructured":"Jiang X, Stockwell BR, Conrad M (2021) Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol 22(4):266\u2013282","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"5","key":"10468_CR18","doi-asserted-by":"publisher","first-page":"938","DOI":"10.2105\/AJPH.2014.302406","volume":"105","author":"TH Keegan","year":"2015","unstructured":"Keegan TH, Kurian AW, Gali K, Tao L, Lichtensztajn DY, Hershman DL et al (2015) Racial\/ethnic and socioeconomic differences in short-term breast cancer survival among women in an integrated health system. Am J Public Health 105(5):938\u2013946","journal-title":"Am J Public Health"},{"issue":"1","key":"10468_CR19","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1182\/blood.V93.1.321","volume":"93","author":"H Kurosawa","year":"1999","unstructured":"Kurosawa H, Goi K, Inukai T, Inaba T, Chang KS, Shinjyo T et al (1999) Two candidate downstream target genes for E2A-HLF. Blood 93(1):321\u2013332","journal-title":"Blood"},{"issue":"2","key":"10468_CR20","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/s41422-019-0263-3","volume":"30","author":"G Lei","year":"2020","unstructured":"Lei G, Zhang Y, Koppula P, Liu X, Zhang J, Lin SH et al (2020) The role of ferroptosis in ionizing radiation-induced cell death and tumor suppression. Cell Res 30(2):146\u2013162","journal-title":"Cell Res"},{"issue":"12","key":"10468_CR21","doi-asserted-by":"publisher","first-page":"2670","DOI":"10.7150\/jca.32072","volume":"10","author":"H Li","year":"2019","unstructured":"Li H, Zhang SR, Xu HX, Wang WQ, Li S, Li TJ et al (2019) SRPX2 and RAB31 are effective prognostic biomarkers in pancreatic cancer. J Cancer 10(12):2670\u20132678","journal-title":"J Cancer"},{"issue":"2","key":"10468_CR22","first-page":"165","volume":"67","author":"X Li","year":"2020","unstructured":"Li X, Liu J, Sun H, Zou Y, Chen J, Chen Y et al (2020) SRPX2 promotes cell proliferation and invasion via activating FAK\/SRC\/ERK pathway in non-small cell lung cancer. Acta Biochim Pol 67(2):165\u2013172","journal-title":"Acta Biochim Pol"},{"issue":"1","key":"10468_CR23","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13045-021-01223-x","volume":"15","author":"H Li","year":"2022","unstructured":"Li H, Yang P, Wang J, Zhang J, Ma Q, Jiang Y et al (2022a) HLF regulates ferroptosis, development and chemoresistance of triple-negative breast cancer by activating tumor cell-macrophage crosstalk. J Hematol Oncol 15(1):2","journal-title":"J Hematol Oncol"},{"issue":"9","key":"10468_CR24","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1038\/s41419-022-05242-5","volume":"13","author":"P Li","year":"2022","unstructured":"Li P, Lin Q, Sun S, Yang N, Xia Y, Cao S et al (2022b) Inhibition of cannabinoid receptor type 1 sensitizes triple-negative breast cancer cells to ferroptosis via regulating fatty acid metabolism. Cell Death Dis 13(9):808","journal-title":"Cell Death Dis"},{"issue":"12","key":"10468_CR25","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1016\/j.molcel.2022.03.022","volume":"82","author":"D Liang","year":"2022","unstructured":"Liang D, Minikes AM, Jiang X (2022) Ferroptosis at the intersection of lipid metabolism and cellular signaling. Mol Cell 82(12):2215\u20132227","journal-title":"Mol Cell"},{"issue":"4","key":"10468_CR26","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s12032-015-0548-4","volume":"32","author":"KL Liu","year":"2015","unstructured":"Liu KL, Wu J, Zhou Y, Fan JH (2015) Increased Sushi repeat-containing protein X-linked 2 is associated with progression of colorectal cancer. Med Oncol 32(4):99","journal-title":"Med Oncol"},{"issue":"20","key":"10468_CR27","doi-asserted-by":"publisher","first-page":"11305","DOI":"10.1021\/acs.jmedchem.9b02138","volume":"63","author":"Y Liu","year":"2020","unstructured":"Liu Y, He S, Chen Y, Liu Y, Feng F, Liu W et al (2020) Overview of AKR1C3: inhibitor achievements and disease insights. J Med Chem 63(20):11305\u201311329","journal-title":"J Med Chem"},{"issue":"1","key":"10468_CR28","doi-asserted-by":"publisher","first-page":"101915","DOI":"10.1016\/j.xcrm.2024.101915","volume":"6","author":"Y Liu","year":"2025","unstructured":"Liu Y, Sun Q, Guo J, Yan L, Yan Y, Gong Y et al (2025) Dual ferroptosis induction in N2-TANs and TNBC cells via FTH1 targeting: A therapeutic strategy for triple-negative breast cancer. Cell Rep Med 6(1):101915","journal-title":"Cell Rep Med"},{"issue":"20","key":"10468_CR29","first-page":"4257","volume":"20","author":"QX Luan","year":"2016","unstructured":"Luan QX, Zhang BG, Li XJ, Guo MY (2016) MiR-129-5p is downregulated in breast cancer cells partly due to promoter H3K27m3 modification and regulates epithelial-mesenchymal transition and multi-drug resistance. Eur Rev Med Pharmacol Sci 20(20):4257\u20134265","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"7","key":"10468_CR30","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1093\/hmg\/ddp034","volume":"18","author":"PP Medina","year":"2009","unstructured":"Medina PP, Castillo SD, Blanco S, Sanz-Garcia M, Largo C, Alvarez S et al (2009) The SRY-HMG box gene, SOX4, is a target of gene amplification at chromosome 6p in lung cancer. Hum Mol Genet 18(7):1343\u20131352","journal-title":"Hum Mol Genet"},{"issue":"Pt 1","key":"10468_CR31","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.semcancer.2019.08.027","volume":"67","author":"CS Moreno","year":"2020","unstructured":"Moreno CS (2020) SOX4: the unappreciated oncogene. Semin Cancer Biol 67(Pt 1):57\u201364","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"10468_CR32","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1038\/s41392-022-01110-y","volume":"7","author":"F Peng","year":"2022","unstructured":"Peng F, Liao M, Qin R, Zhu S, Peng C, Fu L et al (2022) Regulated cell death (RCD) in cancer: key pathways and targeted therapies. Signal Transduct Target Ther 7(1):286","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"10468_CR33","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1182\/blood-2012-05-428938","volume":"121","author":"P Ramezani-Rad","year":"2013","unstructured":"Ramezani-Rad P, Geng H, Hurtz C, Chan LN, Chen Z, Jumaa H et al (2013) SOX4 enables oncogenic survival signals in acute lymphoblastic leukemia. Blood 121(1):148\u2013155","journal-title":"Blood"},{"issue":"1","key":"10468_CR34","doi-asserted-by":"publisher","first-page":"499","DOI":"10.3390\/ijms24010449","volume":"24","author":"L Rochette","year":"2022","unstructured":"Rochette L, Dogon G, Rigal E, Zeller M, Cottin Y, Vergely C (2022) Lipid peroxidation and Iron metabolism: two corner stones in the homeostasis control of ferroptosis. Int J Mol Sci 24(1):499","journal-title":"Int J Mol Sci"},{"issue":"23","key":"10468_CR35","doi-asserted-by":"publisher","first-page":"3617","DOI":"10.1093\/hmg\/ddn256","volume":"17","author":"B Royer-Zemmour","year":"2008","unstructured":"Royer-Zemmour B, Ponsole-Lenfant M, Gara H, Roll P, L\u00e9v\u00eaque C, Massacrier A et al (2008) Epileptic and developmental disorders of the speech cortex: ligand\/receptor interaction of wild-type and mutant SRPX2 with the plasminogen activator receptor uPAR. Hum Mol Genet 17(23):3617\u20133630","journal-title":"Hum Mol Genet"},{"issue":"8","key":"10468_CR36","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1007\/s10147-024-02575-3","volume":"29","author":"T Sasaki","year":"2024","unstructured":"Sasaki T, Higashi T, Inoue T (2024) Urological cancer statistics on incidence from 1975 to 2019 and mortality from 1958 to 2022 in Japan. Int J Clin Oncol 29(8):1088\u20131095","journal-title":"Int J Clin Oncol"},{"issue":"5","key":"10468_CR37","first-page":"3213","volume":"11","author":"H Si","year":"2019","unstructured":"Si H, Chen P, Li H, Wang X (2019) Long non-coding RNA H19 regulates cell growth and metastasis via miR-138 in breast cancer. Am J Transl Res 11(5):3213\u20133225","journal-title":"Am J Transl Res"},{"issue":"6","key":"10468_CR38","doi-asserted-by":"publisher","first-page":"e0199399","DOI":"10.1371\/journal.pone.0199399","volume":"13","author":"BM Soteros","year":"2018","unstructured":"Soteros BM, Cong Q, Palmer CR, Sia GM (2018) Sociability and synapse subtype-specific defects in mice lacking SRPX2, a language-associated gene. PLoS ONE 13(6):e0199399","journal-title":"PLoS ONE"},{"issue":"5","key":"10468_CR39","first-page":"392","volume":"21","author":"A Souandaou Athoumani","year":"2024","unstructured":"Souandaou Athoumani A, G\u00fcl \u00d6, Nihal \u00d6m\u00fcr B (2024) Molecular mechanisms of antiproliferative effects of Safranal on cervical cancer: evidence from bioinformatics analysis. Curr Proteom 21(5):392\u2013405","journal-title":"Curr Proteom"},{"issue":"3","key":"10468_CR40","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A et al (2021) Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209\u2013249","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"10468_CR41","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.ccr.2013.04.020","volume":"23","author":"N Tiwari","year":"2013","unstructured":"Tiwari N, Tiwari VK, Waldmeier L, Balwierz PJ, Arnold P, Pachkov M et al (2013) Sox4 is a master regulator of epithelial-mesenchymal transition by controlling Ezh2 expression and epigenetic reprogramming. Cancer Cell 23(6):768\u2013783","journal-title":"Cancer Cell"},{"issue":"4","key":"10468_CR42","doi-asserted-by":"publisher","first-page":"916","DOI":"10.3390\/cancers12040916","volume":"12","author":"E Vagia","year":"2020","unstructured":"Vagia E, Mahalingam D, Cristofanilli M (2020) The landscape of targeted therapies in TNBC. Cancers (Basel) 12(4):916","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10468_CR43","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s13046-023-02720-2","volume":"42","author":"W Wang","year":"2023","unstructured":"Wang W, Lu K, Jiang X, Wei Q, Zhu L, Wang X et al (2023) Ferroptosis inducers enhanced Cuproptosis induced by copper ionophores in primary liver cancer. J Exp Clin Cancer Res 42(1):142","journal-title":"J Exp Clin Cancer Res"},{"issue":"2","key":"10468_CR44","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1007\/s10528-020-10014-x","volume":"59","author":"X Wei","year":"2021","unstructured":"Wei X, Wei Z, Li Y, Tan Z, Lin C (2021) AKR1C1 contributes to cervical Cancer progression via regulating TWIST1 expression. Biochem Genet 59(2):516\u2013530","journal-title":"Biochem Genet"},{"issue":"1","key":"10468_CR45","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.cmet.2022.09.021","volume":"35","author":"F Yang","year":"2023","unstructured":"Yang F, Xiao Y, Ding JH, Jin X, Ma D, Li DQ et al (2023) Ferroptosis heterogeneity in triple-negative breast cancer reveals an innovative immunotherapy combination strategy. Cell Metab 35(1):84\u2013100e108","journal-title":"Cell Metab"},{"issue":"1","key":"10468_CR46","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13058-020-01296-5","volume":"22","author":"L Yin","year":"2020","unstructured":"Yin L, Duan JJ, Bian XW, Yu SC (2020) Triple-negative breast cancer molecular subtyping and treatment progress. Breast Cancer Res 22(1):61","journal-title":"Breast Cancer Res"},{"key":"10468_CR47","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3389\/fphar.2017.00119","volume":"8","author":"CM Zeng","year":"2017","unstructured":"Zeng CM, Chang LL, Ying MD, Cao J, He QJ, Zhu H et al (2017) Aldo-Keto reductase AKR1C1-AKR1C4: functions, regulation, and intervention for Anti-cancer therapy. Front Pharmacol 8:119","journal-title":"Front Pharmacol"},{"key":"10468_CR48","doi-asserted-by":"publisher","first-page":"3149","DOI":"10.2147\/OTT.S158820","volume":"11","author":"M Zhang","year":"2018","unstructured":"Zhang M, Li X, Fan Z, Zhao J, Liu S, Zhang M et al (2018) High SRPX2 protein expression predicts unfavorable clinical outcome in patients with prostate cancer. Onco Targets Ther 11:3149\u20133157","journal-title":"Onco Targets Ther"},{"issue":"7","key":"10468_CR49","doi-asserted-by":"publisher","first-page":"3167","DOI":"10.7150\/thno.52028","volume":"11","author":"Z Zhang","year":"2021","unstructured":"Zhang Z, Lu M, Chen C, Tong X, Li Y, Yang K et al (2021) Holo-lactoferrin: the link between ferroptosis and radiotherapy in triple-negative breast cancer. Theranostics 11(7):3167\u20133182","journal-title":"Theranostics"},{"issue":"1","key":"10468_CR50","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41420-024-01892-w","volume":"10","author":"S Zhen","year":"2024","unstructured":"Zhen S, Jia Y, Zhao Y, Wang J, Zheng B, Liu T et al (2024) NEAT1_1 confers gefitinib resistance in lung adenocarcinoma through promoting AKR1C1-mediated ferroptosis defence. Cell Death Discov 10(1):131","journal-title":"Cell Death Discov"},{"issue":"47","key":"10468_CR51","doi-asserted-by":"publisher","first-page":"e2103919","DOI":"10.1002\/smll.202103919","volume":"17","author":"L Zhou","year":"2021","unstructured":"Zhou L, Chen J, Li R, Wei L, Xiong H, Wang C et al (2021) Metal-Polyphenol-Network coated Prussian blue nanoparticles for synergistic ferroptosis and apoptosis via triggered GPX4 inhibition and concurrent in situ bleomycin toxification. Small 17(47):e2103919","journal-title":"Small"}],"container-title":["Journal of Molecular Histology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10735-025-10468-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10735-025-10468-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10735-025-10468-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T13:52:41Z","timestamp":1757253161000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10735-025-10468-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,15]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["10468"],"URL":"https:\/\/doi.org\/10.1007\/s10735-025-10468-6","relation":{},"ISSN":["1567-2379","1567-2387"],"issn-type":[{"value":"1567-2379","type":"print"},{"value":"1567-2387","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,15]]},"assertion":[{"value":"24 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study had been authorized by the Ethics Committee of Nantong First People\u2019s Hospital. Each participant in this research gave their consent after being fully informed.\u00a0Authorization for xenograft experiments was given by the Committee on Animal Welfare and Utilization of Nantong First People\u2019s Hospital.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Ethics approval and consent to participate"}},{"value":"Not\u00a0applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Consent for publication"}}],"article-number":"226"}}